A&D HOLON Holdings Company, Limited (TYO:7745)
Japan flag Japan · Delayed Price · Currency is JPY
2,739.00
-149.00 (-5.16%)
Nov 4, 2026, 3:30 PM JST

TYO:7745 Financials Overview

Millions JPY. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
69,15369,32667,08361,95559,02851,736
Revenue Growth
2.11%3.34%8.28%4.96%14.09%6.84%
Gross Profit
31,38131,45130,20327,62026,30322,883
Operating Income
8,5009,2108,8137,9567,4765,497
Net Income
5,5605,9236,4685,2995,5243,573
Earnings Per Share
202.86216.13235.41192.73201.14172.66
EPS Growth
-19.79%-8.19%22.14%-4.18%16.50%6.91%

Revenue by Segment

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Semiconductor-Related Business - Japan
9,10011,11012,29510,3296,916-
Semiconductor-Related Business - Asia and Oceania
-15----
Measurement and Weighing Equipment Business - Americas
5,1365,0924,8184,8186,0013,965
Measurement and Weighing Equipment Business- Japan
24,00923,93920,93220,93219,84424,849
Measurement and Weighing Equipment Business - Asia and Oceania
9,4639,1327,4917,4918,1206,996
Measurement and Weighing Equipment Business - Europe
654618601601905869
Medical and Health Equipment Business- Americas
11,79011,13710,0069,7639,2897,628
Medical and Health Equipment Business - Japan
17,96317,04717,69316,48017,07815,224
Medical and Health Equipment Business - Asia and Oceania
9,0378,3928,6618,2119,0747,803
Medical and Health Equipment Business - Europe
11,03410,5988,8208,0329,3957,826
Unallocated Adjustment
-29,103-27,758-24,705-24,705-27,598-23,426
Total
69,14969,32266,61261,95259,02451,734

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
14,64113,75813,34614,64215,00311,882
Total Debt
11,76712,75013,57917,84221,82019,372
Net Cash (Debt)
2,8741,008-233-3,200-6,817-7,490
Net Cash Growth
------
Net Cash Per Share
104.8636.78-8.48-116.37-248.20-361.87

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-6,4696,5787,2014,0961,782
Capital Expenditures
--3,047-1,525-1,674-885-2,071
Free Cash Flow
-3,4225,0535,5273,211-289
Free Cash Flow Growth
--32.28%-8.58%72.13%--

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
45.38%45.37%45.02%44.58%44.56%44.23%
Operating Margin
12.29%13.29%13.14%12.84%12.67%10.63%
Pretax Margin
11.54%12.50%13.56%12.83%12.82%10.69%
Profit Margin
8.04%8.54%9.64%8.55%9.36%6.91%
FCF Margin
-4.94%7.53%8.92%5.44%-0.56%

Dividends

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Dividend Per Share
60.00055.00040.00035.00035.00025.000
Dividend Per Share Growth
33.33%37.50%14.29%0%40.00%0%
Dividend Yield
2.19%2.20%2.18%1.21%2.46%2.58%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
13.5011.567.7615.047.085.60
Forward PE
14.1811.337.2912.687.817.98
P/FCF Ratio
21.9520.029.9314.4212.17-
PS Ratio
1.090.990.751.290.660.39